Psychological distress and progression to AIDS in a cohort of injection drug users

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 4, 2003, Pages 429-434

  Golub, Elizabeth T ^a   Astemborski, Jacquie A ^a   Hoover, Donald R ^b   Anthony, James C ^a   Vlahov, David ^a,c   Strathdee, Steffanie A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Drug users; Epidemiology; Progression; Psychosocial

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISTRESS SYNDROME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RACE DIFFERENCE; RISK FACTOR; SEROLOGY; SEX DIFFERENCE; THRUSH; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BALTIMORE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV-1; HUMANS; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; STRESS, PSYCHOLOGICAL; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; VIRAL LOAD;

EID: 0037378665     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304010-00013     Document Type: Article

References (30)

1. Uchino BN, Kiecolt-Glaser JK, Cacioppo JT. Age-related changes in cardiovascular response as a function of a chronic stressor and social support. J Pers Soc Psychol 1992;63:839-46.
2. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull 1996;119:488-531.
3. Petitto JM, Leserman J, Perkins DO, et al. High versus low basal cortisol secretion in asymptomatic, medication-free HIV-infected men: differential effects of severe life stress on parameters of immune status. Behav Med 2000;25:143-51.
4. Perry S, Fishman B. Depression and HIV: how does one affect the other? JAMA 1993;270:2609-10.
5. Rabkin IG, Williams JBW, Remien RH, et al. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry 1991;48:111-9.
6. Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med 1999;61:397-406.
7. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA 1993;270:2563-7.
8. Burack JH, Barrett DC, Stall RD, et al. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993; 270:2568-73.
9. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA 2001;285:1466-74.
10. Hartgers C, Van den Hoek JA, Coutinho RA, et al. Psychopathology, stress and HIV-risk injecting behavior among drug users. Br J Addict 1992;87:857-65.
11. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001;58:721-8.
12. Swift W, Williams G, Neill O, et al. The prevalence of minor psychopathology in opioid users seeking treatment. Br J Addict 1990;85:629-34.
13. Darke S, Swift W, Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994;89:211-7.
14. Carey MP, Carey KB, Meisler AW. Psychiatric symptoms in mentally ill chemical abusers. J Nerv Ment Dis 1991;179:136-8.
15. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:643-54.
16. AIDS Administration, Maryland Department of Health and Mental Hygiene. Maryland HIV/AIDS update. Baltimore: Maryland Department of Health and Mental Hygiene, 2001.
17. Vlahov D, Anthony JC, Mufioz A, et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991;21:759-76.
18. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mort Wkly Rep 1987;36:1-15S.
19. Federman EB. An investigation of the association between psychiatric distress and HIV infection in a cohort of injecting drug users [doctoral dissertation]. Baltimore: Johns Hopkins University School of Hygiene and Public Health, 1996.
20. Samuels JF, Nestadt G, Anthony JC, et al. The detection of mental disorders in the community using a 20-item interview version of the General Health Questionnaire. Acta Psychiatr Scand 1994;89:14-20.
21. Goldberg DP. The detection of psychiatric illness by questionnaire. London: Oxford University Press, 1972.
22. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979;9:139-45.
23. Goldberg D. Manual of the general health questionnaire. Windsor, UK: NFER Publishing Company, 1978.
24. Kirby AJ, Muñoz A, Detels R, et al. Thrush and fever as measures of immunocompetence in HIV-1-infected men. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:1242-9.
25. Mellors JW, Rinaldo CR, Jr, Gupta P, et al. Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
26. Mellors JW, Mufioz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
27. Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998;279:35-40.
28. Goldberg D, Huxley P. Common mental disorders: a bio-social model. London: Tavistock, 1992.
29. Holzemer WL, Corless IB, Nokes KM, et al Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs 1999;13:185-97.
30. Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-9.